Adapted physical activity and diet (APAD) during adjuvant breast cancer therapy: Design and implementation of a prospective randomized controlled trial

Contemporary Clinical Trials

Volumn 36, Issue 2, 2013, Pages 531-543

  Carayol, Marion ^a,b   Romieu, Gilles ^c   Bleuse, Jean Pierre ^c   Senesse, Pierre ^c   Gourgou Bourgade, Sophie ^c   Sari, Chakib ^c   Jacot, William ^c   Sancho Garnier, Hélène ^c   Janiszewski, Chloé ^c   Launay, Silène ^c   Cousson Gélie, Florence ^a,c   Ninot, Grégory ^a  

^a University of Montpellier   (France)

^b Faculté de Médecine Centre Hospitalo universitaire   (France)

^c CENTRE VAL D AURELLE   (France)

Author keywords

Breast cancer; Diet; Fatigue; Physical activity; Quality of life; Randomized controlled trial

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL;

ADAPTED PHYSICAL ACTIVITY AND DIET COUNSELING; ADULT; AGED; ANXIETY; ARTICLE; BODY COMPOSITION; BODY WEIGHT; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER FATIGUE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DEPRESSION; DIETARY INTAKE; EXERCISE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PATIENT COUNSELING; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT;

BREAST CANCER; DIET; FATIGUE; PHYSICAL ACTIVITY; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED TRIAL;

ADULT; BREAST NEOPLASMS; CLINICAL PROTOCOLS; COUNSELING; DIET; EXERCISE THERAPY; FEMALE; HUMANS; MOTOR ACTIVITY; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84886249927     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2013.09.016     Document Type: Article

References (60)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108.
2. Bélot A., Velten M., Grosclaude P., Bossard N., Launoy G., Remontet L., et al. French national estimation of cancer incidence and mortality rates between 1980 and 2005 2008, Institut de veille sanitaire, Saint-Maurice, France, [132 pp. Available at www.invs.sante.fr Accessed December 21, 2012].
3. Partridge A.H., Burstein H.J., Winer E.P. Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. J Natl Cancer Inst Monogr 2001, 30:135-142.
4. Truong P.T., Olivotto I.A., Whelan T.J., Levine M. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ 2004, 170(8):1263-1273.
5. National Comprehensive Cancer Network Clinical practice guidelines in oncology. Cancer-related fatigue Version 1 2011; Available from, [Accessed August 21, 2013]. http://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdf.
6. Holley S. Cancer-related fatigue. Suffering a different fatigue. Cancer Pract 2000, 8(2):87-95.
7. Vogelzang N.J., Breitbart W., Cella D., Curt G.A., Groopman J.E., Horning S.J., et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 1997, 34(3 Suppl. 2):4-12.
8. Ahlberg K., Ekman T., Gaston-Johansson F., Mock V. Assessment and management of cancer-related fatigue in adults. Lancet 2003, 362(9384):640-650.
9. Borneman T., Piper B.F., Koczywas M., Munevar C.M., Sun V., Uman G.C., et al. A qualitative analysis of cancer-related fatigue in ambulatory oncology. Clin J Oncol Nurs 2012, 16(1):E26-E32.
10. Broeckel J.A., Jacobsen P.B., Horton J., Balducci L., Lyman G.H. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 1998, 16(5):1689-1696.
11. Curt G.A. Impact of fatigue on quality of life in oncology patients. Semin Hematol 2000, 37(4 Suppl. 6):14-17.
12. Dodd M.J., Miaskowski C., Paul S.M. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 2001, 28(3):465-470.
13. Jacobsen P.B., Hann D.M., Azzarello L.M., Horton J., Balducci L., Lyman G.H. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage 1999, 18(4):233-242.
14. Kalman D., Villani L.J. Nutritional aspects of cancer-related fatigue. J Am Diet Assoc 1997, 97(6):650-654.
15. Demark-Wahnefried W., Case L.D., Blackwell K., Marcom P.K., Kraus W., Aziz N., et al. Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. Clin Breast Cancer 2008, 8(1):70-79.
16. Cramp F., Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2012, 11:CD006145.
17. Carayol M., Bernard P., Boiche J., Riou F., Mercier B., Cousson-Gelie F., et al. Psychological effect of exercise in women with breast cancer receiving adjuvant therapy: what is the optimal dose needed?. Ann Oncol 2013, 24(2):291-300.
18. Carayol M., Delpierre C., Ninot G. A meta-analysis on the interest of exercise in adjuvant breast cancer patients: are the guidelines based on evidence?. Support Care Cancer 2013, 21(Suppl. 1):S187.
19. Schmitz K.H., Courneya K.S., Matthews C., Demark-Wahnefried W., Galvao D.A., Pinto B.M., et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010, 42(7):1409-1426.
20. Smets E.M., Garssen B., Bonke B., De Haes J.C. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39(3):315-325.
21. Boutitie F., Bellissant E., Blanchard J., Boissel J.P., Cauquil J., Chauvin F., et al. Monitoring of clinical-trials and interim analyses-2-Statistical methods. Therapie 1992, 47(4):351-355.
22. Courneya K.S., Segal R.J., Mackey J.R., Gelmon K., Reid R.D., Friedenreich C.M., et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 2007, 25(28):4396-4404.
23. Rabin R., de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001, 33(5):337-343.
24. Conner-Spady B., Cumming C., Nabholtz J.M., Jacobs P., Stewart D. Responsiveness of the EuroQol in breast cancer patients undergoing high dose chemotherapy. Qual Life Res 2001, 10(6):479-486.
25. Chevalier J., de Pouvourville G. Valuing EQ-5D using time trade-off in France. Eur J Health Econ 2013, 14(1):57-66.
26. World Cancer Research Fund/American Institute for Cancer Research Policy and action for cancer prevention. Food, nutrition, and physical activity: a global perspective 2009, AICR, Washington DC, [Available at www.wcrf.org Accessed August 21, 2013].
27. INSERM Group Expertise Physical activity: context and health impact 2008, Les Editions Inserm, Paris.
28. Courneya K.S., Mackey J.R., McKenzie D.C. Exercise for breast cancer survivors: research evidence and clinical guidelines. Phys Sportsmed 2002, 30(8):33-42.
29. de Jong N., Kester A.D., Schouten H.C., Abu-Saad H.H., Courtens A.M. Course of fatigue between two cycles of adjuvant chemotherapy in breast cancer patients. Cancer Nurs 2006, 29(6):467-477.
30. Miller M., Maguire R., Kearney N. Patterns of fatigue during a course of chemotherapy: results from a multi-centre study. Eur J Oncol Nurs 2007, 11(2):126-132.
31. Abraham C., Michie S. A taxonomy of behavior change techniques used in interventions. Health Psychol 2008, 27(3):379-387.
32. Biddle S.J.H., Fox K., Boutcher S.H., Faulkner G. The way forward for physical activity and the promotion of psychological well-being. Physical activity and psychological well-being 2000, 154-168. Routledge, London. S.J.H. Biddle, K. Fox, S.H. Boutcher, G. Faulkner (Eds.).
33. Roza A.M., Shizgal H.M. The Harris Benedict equation reevaluated: resting energy requirements and the body cell mass. Am J Clin Nutr 1984, 40(1):168-182.
34. GENI: Nutritional Analysis Software, release 8 2007, 6. MICRO, Villiers-les-Nancy.
35. Coord Martin A. Dietary reference intake for the French population 2001, CNERNA-CNRS, AFSSA, France, [Paris]. 3rd ed. Tec et Doc (Ed.).
36. von Gruenigen V.E., Courneya K.S., Gibbons H.E., Kavanagh M.B., Waggoner S.E., Lerner E. Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: a randomized trial. Gynecol Oncol 2008, 109(1):19-26.
37. Morey M.C., Snyder D.C., Sloane R., Cohen H.J., Peterson B., Hartman T.J., et al. Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial. JAMA 2009, 301(18):1883-1891.
38. Campbell M.K., Carr C., Devellis B., Switzer B., Biddle A., Amamoo M.A., et al. A randomized trial of tailoring and motivational interviewing to promote fruit and vegetable consumption for cancer prevention and control. Ann Behav Med 2009, 38(2):71-85.
39. Bloom J.R., Stewart S.L., D'Onofrio C.N., Luce J., Banks P.J. Addressing the needs of young breast cancer survivors at the 5year milestone: can a short-term, low intensity intervention produce change?. J Cancer Surviv 2008, 2(3):190-204.
40. Markes M., Brockow T., Resch K.L. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev 2006, 4:CD005001.
41. McNeely M.L., Campbell K.L., Rowe B.H., Klassen T.P., Mackey J.R., Courneya K.S. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 2006, 175(1):34-41.
42. Haines T.P., Sinnamon P., Wetzig N.G., Lehman M., Walpole E., Pratt T., et al. Multimodal exercise improves quality of life of women being treated for breast cancer, but at what cost? Randomized trial with economic evaluation. Breast Cancer Res Treat 2010, 124(1):163-175.
43. Giles-Corti B., Donovan R.J. Socioeconomic status differences in recreational physical activity levels and real and perceived access to a supportive physical environment. Prev Med 2002, 35(6):601-611.
44. Giles-Corti B., Donovan R.J. The relative influence of individual, social and physical environment determinants of physical activity. Soc Sci Med 2002, 54(12):1793-1812.
45. Thorpe K.E., Zwarenstein M., Oxman A.D., Treweek S., Furberg C.D., Altman D.G., et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ 2009, 180(10):E47-E57.
46. Zwarenstein M., Treweek S., Gagnier J.J., Altman D.G., Tunis S., Haynes B., et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008, 337:a2390.
47. Jones C.J., Rikli R.E., Beam W.C. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport 1999, 70(2):113-119.
48. Winters-Stone K.M., Bennett J.A., Nail L., Schwartz A. Strength, physical activity, and age predict fatigue in older breast cancer survivors. Oncol Nurs Forum 2008, 35(5):815-821.
49. Test for attentional performance (TAP) P Zimmermann, B Fimm - PsyTest, Herzogenrath 1995.
50. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85(5):365-376.
51. Razavi D., Delvaux N., Farvacques C., Robaye E. Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry 1990, 156:79-83.
52. Bull F.C., Maslin T.S., Armstrong T. Global physical activity questionnaire (GPAQ): nine country reliability and validity study. J Phys Act Health 2009, 6(6):790-804.
53. Yaw Y.H., Shariff Z.M., Kandiah M., Mun C.Y., Yusof R.M., Othman Z., et al. Weight changes and lifestyle behaviors in women after breast cancer diagnosis: a cross-sectional study. BMC Public Health 2011, 11:309.
54. Cereda E., Turrini M., Ciapanna D., Marbello L., Pietrobelli A., Corradi E. Assessing energy expenditure in cancer patients: a pilot validation of a new wearable device. JPEN J Parenter Enteral Nutr 2007, 31(6):502-507.
55. Fredrix E.W., Saris W.H., Soeters P.B., Wouters E.F., Kester A.D., von Meyenfeldt M.F., et al. Estimation of body composition by bioelectrical impedance in cancer patients. Eur J Clin Nutr 1990, 44(10):749-752.
56. Sarhill N., Mahmoud F.A., Christie R., Tahir A. Assessment of nutritional status and fluid deficits in advanced cancer. Am J Hosp Palliat Care 2003, 20(6):465-473.
57. Gupta D., Lammersfeld C.A., Vashi P.G., King J., Dahlk S.L., Grutsch J.F., et al. Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer 2008, 8:249.
58. Biro G., Hulshof K.F., Ovesen L., Amorim Cruz J.A. Selection of methodology to assess food intake. Eur J Clin Nutr 2002, 56(Suppl 2):S25-S32.
59. Sass C., Dupre C., Dauphinot V., et al. The EPICES score: an individual index of material and social deprivation related to health status. Part 2: evaluation in a population of 197 389 subjects [article online] 2005, Available from http://www.cetaf.asso.fr/protocoles/precarite/protocoles_epices.htm#publis.
60. Sass C., Gueguen R., Moulin J.J., Abric L., Dauphinot V., Dupre C., et al. Comparison of the individual deprivation index of the French Health Examination Centres and the administrative definition of deprivation. Sante Publique 2006, 18(4):513-522.